Maurizio Vecchione represents Global Good to deliver the presentation on Reverse Innovation in Global Health and Global Development to drive catalytic invention, with the power to move the bottom Billion into the Sustainable Development Goals. Case studies include AI-based Microscopy, Photonic Fence for vector control in health and agriculture eradication, High Sensitivity Point of Care Diagnostics for disease eradication.
14. Like a Pregnancy Test, But More Powerful
• As clinically sensitive as PCR
• Asymptomatic malaria
• TB detection from urine
• Quantitative results
• Made and distributedby the
suppliersof current test strips,
at similar cost
16. Guiding the Polio Campaign in Nigeria
Upfill-Brown et al., BMC Medicine 2014
17. Partnering for Invention
Government, Multilateral
NGO and Commercial
Sectors
Late stage
Execution
Invention Technology
Development
Product
Development
Piloting
Clinical
and
Field
trials
Manufacturing
Capacity
Sales
Marketing
Distribution
Early stage
High risk
To date, the tremendous power of invention has been focused on transforming lives that don’t really need to be transformed. In 2011, Booz & Co. estimated that the top 1000 publicly-listed R&D spenders spent roughly $600B. That included $170B just within the computer and electronics industry. In contrast, G-FINDER estimated that just $3B was spent that same year on R&D for the 34 diseases they classify as neglected. The majority of that went toward HIV, TB & malaria. It’s not just a funding issue, though, it’s a question of where our collective brainpower is focused.
Booz & Co; http://www.booz.com/global/home/what-we-think/global-innovation-1000 (1000 Largest publicly listed R&D spenders)
G-FINDER: http://www.policycures.org/downloads/GF2012_Report.pdf
Here’s another problem we tackled that illustrates the necessity of sometimes accepting failure and moving on.
When we went to Uganda to understand how vaccines are actually stored and transported in this part of the world, it wasn’t hard to see the problem.
So after about five years of trials and a lot of error, we came up with this vaccine carrier, which can keep vaccines cold for months without power, and even track the entire temperature history of the content. It is now being manufactured by a spin-off of ours named Arktek.
We’re confident it’s going to succeed because we took each of our earlier prototypes into the field and saw them fail in every conceivable way.
And we learned what not to do from each of those failures. So when we took this model to field trials, people used it, they liked it--it just worked.
Senegal 2013 with several of our partners from PATH and the ministry of health
• Malaria is a tough target to spot -- few people in the world can do it accurately.
• Identifying malaria parasites via microscope is equivalent to finding a handful of marbles in a football field.
• Using machine learning, our scientists and algorithm experts ‘trained’ a microscope to recognize malaria parasites in a blood smear.
• This “smart microscope” technology can provide all health workers with gold standard diagnosis of Malaria (and other diseases to follow).
Millions die annually from problems that science and technology can potentially solve.
We’re working to create affordable, accessible, appropriate solutions.
Unlike traditional corporate charity, our innovations are powered by market demand; Our business model harnesses marketplace incentives for long-term sustainability.
We team with leading humanitarian organizations, forward-looking governments, and commercial partners who share our vision.